<DOC>
	<DOCNO>NCT02223065</DOCNO>
	<brief_summary>The purpose study demonstrate bioequivalence coadministered drug healthy subject .</brief_summary>
	<brief_title>Bioequivalence Study Coadministered Healthy Subjects Fasted State</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>1 . Signed Informed Consent Form Signed write informed consent must obtain subject accordance requirement study center 's IRB IEC initiation protocolrequired procedure . 2 . Target Population Healthy subject determine clinically significant deviation normal medical history , psychiatric history , physical examination finding , vital sign measurement , 12lead ECG measurement , physical measurement , clinical laboratory test result . 3 . Age Reproductive Status Males female , age 19 55 year , inclusive . To extent possible , distribution men woman sequence balance Women childbearing potential ( WOCBP ) must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 24 hour prior start study drug . Women must breastfeed . ) WOCBP must agree follow instruction method ( ) contraception duration treatment study drug saxagliptin dapagliflozin plus 5 half life study drug dapagliflozin ( longer half life 2 drug ; 3 day ) total 3 day follow treatment completion . e ) Men sexually active WOCBP must agree follow instruction method ( ) contraception duration treatment study drug saxagliptin dapagliflozin plus 5 half life dapagliflozin ( longer half life 2 drug ; 3 day ) total 3 day follow treatment completion . f ) Azoospermic male WOCBP continuously heterosexually active exempt contraceptive requirement . However , must still undergo pregnancy test described section Any significant acute chronic medical illness . Current recent ( within 3 month study drug administration ) gastrointestinal disease could impact upon absorption study drug Any sound medical , psychiatric , and/or social reason determine investigator Any major surgery within 4 week study drug administration . Any prior GI surgery include cholecystectomy ( remote history appendectomy exclusionary ) . Current , recent ( within 3 month study drug administration ) , remote history pancreatitis . Donation blood plasma blood bank clinical study ( except screen visit ) within 4 week study drug administration . Blood transfusion within 4 week study drug administration . h ) Inability tolerate oral medication . Inability venipunctured perform and/or tolerate venous access . Use tobacco nicotinecontaining product ( include , limited , cigarette , pipe , ecigarettes , cigar , chew tobacco , nicotine patch , nicotine lozenge , nicotine gum ) within 6 month checkin . Drug alcohol abuse ( within 2 year study drug administration ) define Diagnostic Statistical Manual Mental Disorders 4th Edition , Diagnostic Criteria Drug Alcohol Abuse History glucose intolerance diabetes mellitus . For female , history chronic recurrent urinary tract infection ( UTI ) ( define 3 occurrence per year ) UTI past 3 month . For male , UTI within previous 5 year thoroughly evaluate explanation clear . History recurrent ( defined 3 occurrence per year ) recent vulvovaginal mycotic infection . Any sound medical , psychiatric , and/or social reason determine investigator . Physical Laboratory Test Findings 1 . Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECGs , clinical laboratory determination beyond consistent target population . 2 . Abnormal urinalysis screening ( may repeat ) . If urinalysis abnormal Day 1 Period 1 , continuation study investigator 's discretion . The CRO medical monitor consult . 3 . Glucosuria hematoria screen Day 1 Period 1 , repeat permit . ) A positive nicotine test ( ie , cotinine ) . e ) Abnormal liver function test ( alanine aspartate aminotransferase [ ALT AST , respectively ] , total bilirubin ) . f ) Any follow 12lead ECG prior study drug administration , confirm repeat . ) PR ≥ 210 m ii ) QRS ≥ 120 m iii ) QT ≥ 500 m iv ) QTcF ≥ 450 m g ) Positive urine screen drug abuse . h ) Positive urine alcohol test . ) Positive blood screen hepatitis C virus ( HCV ) antibody , hepatitis B surface antigen ( HBsAg ) , human immunodeficiency virus ( HIV ) 1 HIV2 antibody screen . 4 . Allergies Adverse Drug Reaction 1 . History allergy adverse reaction DPP4 SGLT inhibitor related compound . 2 . History significant drug allergy ( anaphylaxis hepatotoxicity ) . 5 . Other Exclusion Criteria 1 . Prisoners subject involuntarily incarcerate . 2 . Subjects compulsorily detain treatment either psychiatric physical ( eg , infectious disease ) illness . 3 . Inability comply restriction prohibit activities/treatments</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>